CIP2A_HUMAN - dbPTM
CIP2A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CIP2A_HUMAN
UniProt AC Q8TCG1
Protein Name Protein CIP2A {ECO:0000305}
Gene Name CIP2A {ECO:0000312|HGNC:HGNC:29302}
Organism Homo sapiens (Human).
Sequence Length 905
Subcellular Localization Membrane
Single-pass membrane protein . Cytoplasm . Slightly concentrates in the perinuclear region (PubMed:12118381).
Protein Description Oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation..
Protein Sequence MDSTACLKSLLLTVSQYKAVKSEANATQLLRHLEVISGQKLTRLFTSNQILTSECLSCLVELLEDPNISASLILSIIGLLSQLAVDIETRDCLQNTYNLNSVLAGVVCRSSHTDSVFLQCIQLLQKLTYNVKIFYSGANIDELITFLIDHIQSSEDELKMPCLGLLANLCRHNLSVQTHIKTLSNVKSFYRTLITLLAHSSLTVVVFALSILSSLTLNEEVGEKLFHARNIHQTFQLIFNILINGDGTLTRKYSVDLLMDLLKNPKIADYLTRYEHFSSCLHQVLGLLNGKDPDSSSKVLELLLAFCSVTQLRHMLTQMMFEQSPPGSATLGSHTKCLEPTVALLRWLSQPLDGSENCSVLALELFKEIFEDVIDAANCSSADRFVTLLLPTILDQLQFTEQNLDEALTRKKCERIAKAIEVLLTLCGDDTLKMHIAKILTTVKCTTLIEQQFTYGKIDLGFGTKVADSELCKLAADVILKTLDLINKLKPLVPGMEVSFYKILQDPRLITPLAFALTSDNREQVQSGLRILLEAAPLPDFPALVLGESIAANNAYRQQETEHIPRKMPWQSSNHSFPTSIKCLTPHLKDGVPGLNIEELIEKLQSGMVVKDQICDVRISDIMDVYEMKLSTLASKESRLQDLLETKALALAQADRLIAQHRCQRTQAETEARTLASMLREVERKNEELSVLLKAQQVESERAQSDIEHLFQHNRKLESVAEEHEILTKSYMELLQRNESTEKKNKDLQITCDSLNKQIETVKKLNESLKEQNEKSIAQLIEKEEQRKEVQNQLVDREHKLANLHQKTKVQEEKIKTLQKEREDKEETIDILRKELSRTEQIRKELSIKASSLEVQKAQLEGRLEEKESLVKLQQEELNKHSHMIAMIHSLSGGKINPETVNLSI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDSTACLK
-------CCHHHHHH
9.1819413330
3Phosphorylation-----MDSTACLKSL
-----CCHHHHHHHH
19.3330631047
4Phosphorylation----MDSTACLKSLL
----CCHHHHHHHHH
19.6830631047
8UbiquitinationMDSTACLKSLLLTVS
CCHHHHHHHHHHHHH
38.65-
9PhosphorylationDSTACLKSLLLTVSQ
CHHHHHHHHHHHHHH
15.9921406692
13PhosphorylationCLKSLLLTVSQYKAV
HHHHHHHHHHHHHHH
20.3421406692
15PhosphorylationKSLLLTVSQYKAVKS
HHHHHHHHHHHHHHC
23.6621406692
17PhosphorylationLLLTVSQYKAVKSEA
HHHHHHHHHHHHCCC
8.0721406692
18UbiquitinationLLTVSQYKAVKSEAN
HHHHHHHHHHHCCCC
38.7829967540
21AcetylationVSQYKAVKSEANATQ
HHHHHHHHCCCCHHH
47.6525953088
21UbiquitinationVSQYKAVKSEANATQ
HHHHHHHHCCCCHHH
47.6527667366
40MalonylationLEVISGQKLTRLFTS
HHHHCCCCHHHHHCC
56.1826320211
40 (in isoform 1)Ubiquitination-56.1821906983
40UbiquitinationLEVISGQKLTRLFTS
HHHHCCCCHHHHHCC
56.1827667366
40AcetylationLEVISGQKLTRLFTS
HHHHCCCCHHHHHCC
56.1823236377
92S-nitrosylationVDIETRDCLQNTYNL
CCCCHHHHHHHCCCC
3.6719483679
92S-nitrosocysteineVDIETRDCLQNTYNL
CCCCHHHHHHHCCCC
3.67-
108S-nitrosylationSVLAGVVCRSSHTDS
HHHHHHHHCCCCCCH
3.0319483679
108S-nitrosocysteineSVLAGVVCRSSHTDS
HHHHHHHHCCCCCCH
3.03-
234PhosphorylationHARNIHQTFQLIFNI
HHCCHHHHHHHHHHH
10.13-
248PhosphorylationILINGDGTLTRKYSV
HHHCCCCCCCEEHHH
29.69-
250PhosphorylationINGDGTLTRKYSVDL
HCCCCCCCEEHHHHH
25.59-
253PhosphorylationDGTLTRKYSVDLLMD
CCCCCEEHHHHHHHH
15.61-
275UbiquitinationADYLTRYEHFSSCLH
HHHHHHHHHHHHHHH
34.8622505724
297UbiquitinationGKDPDSSSKVLELLL
CCCCCCHHHHHHHHH
30.6422505724
315UbiquitinationSVTQLRHMLTQMMFE
HHHHHHHHHHHHHHH
3.3322817900
322UbiquitinationMLTQMMFEQSPPGSA
HHHHHHHHCCCCCCC
32.0527667366
333UbiquitinationPGSATLGSHTKCLEP
CCCCCCCCCCCCCHH
30.9721963094
402UbiquitinationDQLQFTEQNLDEALT
HHHHHHHCCHHHHHH
53.3722053931
409PhosphorylationQNLDEALTRKKCERI
CCHHHHHHHHHHHHH
47.7120071362
430UbiquitinationLLTLCGDDTLKMHIA
HHHHHCCHHHHHHHH
38.9422505724
438UbiquitinationTLKMHIAKILTTVKC
HHHHHHHHHHHHHCC
37.3329967540
441PhosphorylationMHIAKILTTVKCTTL
HHHHHHHHHHCCCHH
32.77-
442PhosphorylationHIAKILTTVKCTTLI
HHHHHHHHHCCCHHH
17.96-
452UbiquitinationCTTLIEQQFTYGKID
CCHHHHHHCCCCEEE
21.6222505724
465UbiquitinationIDLGFGTKVADSELC
EEECCCCCCCCHHHH
35.4929967540
470 (in isoform 2)Ubiquitination-59.7521906983
470UbiquitinationGTKVADSELCKLAAD
CCCCCCHHHHHHHHH
59.7522817900
473UbiquitinationVADSELCKLAADVIL
CCCHHHHHHHHHHHH
54.5129967540
474UbiquitinationADSELCKLAADVILK
CCHHHHHHHHHHHHH
4.6624816145
477UbiquitinationELCKLAADVILKTLD
HHHHHHHHHHHHHHH
23.5327667366
488UbiquitinationKTLDLINKLKPLVPG
HHHHHHHHHCCCCCC
51.3921963094
488 (in isoform 2)Ubiquitination-51.3921906983
502UbiquitinationGMEVSFYKILQDPRL
CCEEEHHHHHCCCCC
34.62-
557UbiquitinationIAANNAYRQQETEHI
HHHCCHHHHHCCCCC
29.3322053931
567UbiquitinationETEHIPRKMPWQSSN
CCCCCCCCCCCCCCC
43.9129967540
572PhosphorylationPRKMPWQSSNHSFPT
CCCCCCCCCCCCCCC
29.2825159151
573PhosphorylationRKMPWQSSNHSFPTS
CCCCCCCCCCCCCCC
24.3825159151
576PhosphorylationPWQSSNHSFPTSIKC
CCCCCCCCCCCCCHH
36.8527732954
582UbiquitinationHSFPTSIKCLTPHLK
CCCCCCCHHCCCHHH
23.9829967540
585PhosphorylationPTSIKCLTPHLKDGV
CCCCHHCCCHHHCCC
20.3823312004
588UbiquitinationIKCLTPHLKDGVPGL
CHHCCCHHHCCCCCC
5.9522505724
589UbiquitinationKCLTPHLKDGVPGLN
HHCCCHHHCCCCCCC
49.7722505724
603UbiquitinationNIEELIEKLQSGMVV
CHHHHHHHHHCCCCC
44.8529967540
610UbiquitinationKLQSGMVVKDQICDV
HHHCCCCCCCCCCCE
4.1422505724
611UbiquitinationLQSGMVVKDQICDVR
HHCCCCCCCCCCCEE
32.2932015554
626PhosphorylationISDIMDVYEMKLSTL
HHHHHHHHHHHHHHH
13.17-
628UbiquitinationDIMDVYEMKLSTLAS
HHHHHHHHHHHHHCC
2.6422817900
629 (in isoform 1)Ubiquitination-27.6121906983
629UbiquitinationIMDVYEMKLSTLASK
HHHHHHHHHHHHCCC
27.6121906983
635UbiquitinationMKLSTLASKESRLQD
HHHHHHCCCHHHHHH
39.8227667366
636UbiquitinationKLSTLASKESRLQDL
HHHHHCCCHHHHHHH
54.8527667366
638PhosphorylationSTLASKESRLQDLLE
HHHCCCHHHHHHHHH
41.86-
646UbiquitinationRLQDLLETKALALAQ
HHHHHHHHHHHHHHH
22.9121963094
647 (in isoform 1)Ubiquitination-31.8421906983
647UbiquitinationLQDLLETKALALAQA
HHHHHHHHHHHHHHH
31.8421963094
656MethylationLALAQADRLIAQHRC
HHHHHHHHHHHHHHH
30.89-
685UbiquitinationMLREVERKNEELSVL
HHHHHHHHHHHHHHH
56.0329967540
694UbiquitinationEELSVLLKAQQVESE
HHHHHHHHHHHHHHH
39.7329967540
715UbiquitinationEHLFQHNRKLESVAE
HHHHHHCHHHHHHHH
42.6922053931
716UbiquitinationHLFQHNRKLESVAEE
HHHHHCHHHHHHHHH
63.0222053931
719PhosphorylationQHNRKLESVAEEHEI
HHCHHHHHHHHHHHH
36.7428555341
729UbiquitinationEEHEILTKSYMELLQ
HHHHHHHHHHHHHHH
35.8229967540
740PhosphorylationELLQRNESTEKKNKD
HHHHCCCCHHHHHCC
45.4722210691
741PhosphorylationLLQRNESTEKKNKDL
HHHCCCCHHHHHCCC
45.7222210691
746UbiquitinationESTEKKNKDLQITCD
CCHHHHHCCCHHHHH
69.56-
751PhosphorylationKNKDLQITCDSLNKQ
HHCCCHHHHHHHHHH
9.4120873877
754PhosphorylationDLQITCDSLNKQIET
CCHHHHHHHHHHHHH
35.6720873877
761PhosphorylationSLNKQIETVKKLNES
HHHHHHHHHHHHHHH
38.9717192257
764AcetylationKQIETVKKLNESLKE
HHHHHHHHHHHHHHH
52.817822405
775UbiquitinationSLKEQNEKSIAQLIE
HHHHHHHHHHHHHHH
55.5029967540
783UbiquitinationSIAQLIEKEEQRKEV
HHHHHHHHHHHHHHH
60.6029967540
787UbiquitinationLIEKEEQRKEVQNQL
HHHHHHHHHHHHHHH
40.1424816145
788UbiquitinationIEKEEQRKEVQNQLV
HHHHHHHHHHHHHHH
63.0324816145
800UbiquitinationQLVDREHKLANLHQK
HHHHHHHHHHHHHHH
44.5429967540
820AcetylationEKIKTLQKEREDKEE
HHHHHHHHHHCCHHH
62.9520167786
828PhosphorylationEREDKEETIDILRKE
HHCCHHHHHHHHHHH
25.6624719451
847PhosphorylationEQIRKELSIKASSLE
HHHHHHHHHHHHHHH
24.1223401153
857UbiquitinationASSLEVQKAQLEGRL
HHHHHHHHHHHCCCH
43.1929967540
872UbiquitinationEEKESLVKLQQEELN
HHHHHHHHHHHHHHH
45.9632015554
890PhosphorylationHMIAMIHSLSGGKIN
HHHHHHHHHHCCCCC
17.1929449344
892PhosphorylationIAMIHSLSGGKINPE
HHHHHHHHCCCCCHH
48.8129449344
900PhosphorylationGGKINPETVNLSI--
CCCCCHHHCCCCC--
18.8927251275
904PhosphorylationNPETVNLSI------
CHHHCCCCC------
22.5025159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
904SPhosphorylationKinasePLK1P53350
PSP
-KUbiquitinationE3 ubiquitin ligaseSTUB1Q9UNE7
PMID:24293411

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CIP2A_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CIP2A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
2AAA_HUMANPPP2R1Aphysical
17632056
MYC_HUMANMYCphysical
17632056
EGFR_HUMANEGFRphysical
23956138
CHIP_HUMANSTUB1physical
24293411
STOM_HUMANSTOMphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CIP2A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-761 AND SER-904, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-904, AND MASSSPECTROMETRY.

TOP